Updated:
Vygon
Vygon was founded in 1962 by Belgian engineer Pierre Simonet, who established a specialized medical-device manufacturing operation in Écouen, France.
Vygon
Vygon was founded in 1962 by Belgian engineer Pierre Simonet, who established a specialized medical-device manufacturing operation in Écouen, France. The Simonet family retains full control, with Chairman Stéphane Regnault — husband of Simonet's granddaughter — leading governance, and Ludovic Richard-Vitton serving as CEO of Vygon Group since January 2023. The wealth originates from six decades of profitable manufacturing across clinical specialties including neonatology, critical care, and vascular access. The group operates ten owned industrial and logistics properties across France, Germany, Portugal, the United Kingdom, and the United States — a vertically integrated manufacturing footprint that constitutes the bulk of Vygon's asset base. Production sites include the SAP Factory in Saint-Saulve, SIPA Factory in Avesnes-sur-Helpe, and the Perouse Medical facilities in Ivry le Temple and Chaponost, acquired through the 2019 acquisition of Perouse Medical. Real estate holdings spanning production, sterilization, and logistics facilities reflect a deliberate strategy of owning critical infrastructure rather than leasing. The firm deploys capital through direct balance-sheet investment in production capacity, bolt-on acquisitions, and corporate real estate, without reporting a separate AUM figure. Vygon's 2019 acquisition of Perouse Medical expanded its surgical and interventional portfolio. A reported equity stake in Lagrange Ophthalmologie exists through historical corporate records, though current ownership is unconfirmed. The U.S. facility in Lansdale, Pennsylvania, and the UK headquarters in Swindon represent the Anglo-American operational nodes. Vygon's structural differentiator lies in its manufacturing-heavy corporate treasury model — the firm does not operate as a standalone investment office but allocates retained earnings from industrial operations directly into owned production sites, logistics centers, and strategic healthcare M&A. Governance rests with a family-controlled board, with no external shareholders, no reported LP relationships, and no fund structures. This architecture means investment decisions are indistinguishable from industrial strategy, a posture uncommon among diversified family offices.
General information
Firm type
Single Family Office
Year founded
1962
AUM
Undisclosed (Altss estimate: investment portfolio likely exceeds $500M given global manufacturing scale and six-decade operating history)
Location
Region
Europe
Country
France
City
Écouen
Corporate office
8 rue de Paris, 95440 Écouen, France
Additional offices
Swindon, UK · Lansdale, PA, USA · Aachen, Germany · Baltar, Portugal · Verneuil-en-Halatte, France · Ivry le Temple, France · Chaponost, France · Saint-Saulve, France · Avesnes-sur-Helpe, France
Principals
Ludovic Richard-Vitton
Chief Executive Officer, Vygon Group
Stéphane Regnault
Chairman of the Board of Directors
Simonet Family
Controlling Shareholder
Sector focus
Frequently asked questions
Who runs investment decisions at Vygon?
Investment decisions are made by Vygon Group's executive leadership under board governance. CEO Ludovic Richard-Vitton, appointed January 2023, leads operational strategy including capital allocation. Chairman Stéphane Regnault, representing Simonet-family interests, oversees the board. The firm does not employ a dedicated CIO structure — deployment flows through industrial and corporate-development functions rather than a separate investment committee.
Is Vygon a single family office or an operating company with a treasury function?
Vygon is an operating medical-device manufacturer whose retained earnings and corporate treasury function serve as the Simonet family's primary investment vehicle. It does not present as a standalone family office. Balance-sheet assets include ten owned industrial properties across Europe and the US, and strategic acquisitions such as Perouse Medical in 2019, but there is no reported separate investment entity or AUM figure.
How does Vygon's real estate portfolio function within the broader group?
Vygon owns ten production, sterilization, and logistics facilities outright — from the headquarters at 8 rue de Paris in Écouen to factories in Aachen, Baltar, Saint-Saulve, and Lansdale. These properties serve operational rather than rental-income purposes, reflecting a manufacturing-first capital strategy. Owning critical infrastructure hedges against lease-market exposure and supports long production-cycle planning.
Does Vygon operate philanthropic structures, and how are they separated?
Vygon maintains two philanthropic entities — Vygon Helping Others and Vygon Together — that support community and healthcare-access initiatives. The firm also holds patronage of the Château d'Écouen, a French National Museum located in the firm's headquarters town. These structures are operationally separate from the industrial treasury but share governance through family and executive oversight.
Which sectors does Vygon explicitly avoid?
Vygon's investment posture is constrained to healthcare manufacturing adjacencies and real estate supporting its operations. There is no evidence of deployment into financial assets, venture capital, technology outside med-tech, hospitality, or speculative real estate. The firm does not operate a diversified portfolio and has not reported any fund commitments or third-party manager relationships.
How is Vygon's governance structured across the family and executive leadership?
Stéphane Regnault, husband of founder Pierre Simonet's granddaughter, chairs the board and represents the controlling family. Ludovic Richard-Vitton was named CEO in January 2023 following Christophe Mathe's tenure. This dual structure — family chair plus professional CEO — mirrors the governance model seen in other French industrial family groups such as Somfy, though Vygon operates with less public disclosure.
Does Vygon participate in co-investments alongside external partners?
There is no public record of Vygon participating in co-investment clubs, LP commitments, or GP relationships. Its capital deployment appears entirely direct — balance-sheet acquisitions like the 2019 Perouse Medical deal and owned real estate across six countries. This self-funded posture aligns with the firm's vertically integrated manufacturing model.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: